Our partners include the National Institute of Health (NIH)/Vaccine Research Council)VRC), the Gates Foundation, the Center for Epidemic Preparedness Innovations (CEPI), Vanderbilt Medical School, Boston College, and Duke Medical School.

Akagera Medicines Introduction to Strategy, Partners and Product Pipeline

Our partners include the National Institute of Health (NIH) / Vaccine Research Council (VRC), the Gates Foundation, the Center for Epidemic Preparedness Innovations (CEPI), Vanderbilt Medical School, Boston College, and Duke Medical School. Akagera Medicines’ policy is to pay a maximum of 25% indirect costs for research and development agreements.

Akagera Medicines’ science advisors and operating partners provide guidance, “pushback” and validation.

Click here for brief nonconfidential presentation: strategy, Pipeline, IP, etc